Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect

Area of Science:

• Genetics
• Oncology
• Dermatology

Background:

• Multiple primary cancers, including melanoma, can indicate inherited genetic predispositions.
• Germline mutations in predisposing genes, such as CDKN2A, are implicated in familial melanoma.
• Investigating sporadic cases of multiple primary melanoma (MPM) is crucial for understanding genetic contributions outside familial contexts.

Purpose of the Study:

• To investigate the frequency and origin of germline mutations in CDKN2A and CDK4 exon 2 in patients with MPM and no family history.
• To determine if the recurrent G101W mutation in CDKN2A represents a mutational hotspot for de novo mutations or a common founder mutation.

Main Methods:

• Genetic screening of 100 MPM patients without a family history for germline mutations in CDKN2A and CDK4 exon 2.
• Haplotype analysis of microsatellite markers flanking the CDKN2A gene to trace the origin of the G101W mutation.

Main Results:

• Nine out of 100 patients (9%) had germline mutations in CDKN2A; no mutations were found in CDK4 exon 2.
• A recurrent missense mutation (G101W) was identified in seven patients, a novel missense mutation (P114S) in one, and a 6 bp insertion in another.
• Haplotype analysis suggested a common founder origin for the G101W mutation in six out of seven sporadic MPM cases.

Conclusions:

• De novo germline CDKN2A mutations are rare causes of MPM.
• The G101W mutation in CDKN2A is likely a founder mutation rather than a mutational hotspot in sporadic MPM.
• Genetic analysis of sporadic MPM cases can reveal insights into founder effects and rare de novo mutations.